Stock listing

BX Swiss:CN2 Catalyst Pharmaceuticals, Inc. Aktie

Swiss listing (BX Swiss) of Catalyst Pharmaceuticals, Inc. · home listing NASDAQ:CPRX

Follow Catalyst Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Catalyst Pharmaceuticals, Inc. logo
Ticker
BX Swiss:CN2
Asset type
Stock
Exchange
BX Swiss
Currency
CHF

What changed lately

Calls

Replays

  • Catalyst Pharmaceuticals (NASDAQ:CPRX) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 8:30 AM ET

    Watch Transcript

  • Catalyst Pharmaceuticals (NASDAQ:CPRX) Q3 2025 Earnings Call

    Thu, Nov 06, 2025 · 8:30 AM ET

    Watch Transcript

  • Catalyst Pharmaceuticals (NASDAQ:CPRX) Q2 2025 Earnings Call

    Thu, Aug 07, 2025 · 8:30 AM ET

    Watch Transcript

Latest news

Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses

Jun 30, 2026

Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results

May 11, 2026

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease

May 7, 2026

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.

May 7, 2026

Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026

Apr 28, 2026

Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference

Mar 6, 2026

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance

Feb 25, 2026

Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference

Feb 24, 2026

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026

Feb 11, 2026

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies

Jan 8, 2026

All Catalyst Pharmaceuticals, Inc. news

Decks

Catalyst Pharmaceuticals, Inc. on 6ix

News releases
19 in the last 12 months · 182 in all · newest Jun 30, 2026 · oldest 2019
Calls
18 calls with a replay · 18 with a transcript · latest Feb 26, 2026
Decks
6 decks · latest Feb 26, 2026

Where Catalyst Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CPRX · Home listingNASDAQUnited StatesUSD
gettex:CN2gettexGermanyEUR
LS Exchange:A0LCULLS ExchangeGermanyEUR
BOATS:CPRXBOATSUnited StatesUSD
Tradegate:CN2TradegateGermanyEUR
Frankfurt:CN2FrankfurtGermanyEUR
Lang & Schwarz:A0LCULLang & SchwarzGermanyEUR
BX Swiss:CN2 · This pageBX SwissSwitzerlandCHF
Stuttgart:CN2StuttgartGermanyEUR
Dusseldorf:CN2DusseldorfGermanyEUR
Hamburg:CN2HamburgGermanyEUR
Munich:CN2MunichGermanyEUR

Log in to ask 6ix AI your own questions about Catalyst Pharmaceuticals, Inc.